Histone Deacetylase Cytoplasmic Trapping by a Novel Fluorescent HDAC Inhibitor

Inhibitors of histone deacetylases (HDAC) are an important emerging class of drugs for the treatment of cancers. HDAC inhibitors are currently under evaluation in clinical trials as single agents and as sensitizers in combinations with chemotherapies and radiation therapy. Although these drugs have...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Kong, Yali, Jung, Mira, Wang, Kan, Grindrod, Scott, Velena, Alfredo, Lee, Sung A., Dakshanamurthy, Sivanesan, Yang, Yonghong, Miessau, Matthew, Zheng, Chaoyi, Dritschilo, Anatoly, Brown, Milton L.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2011
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3695633/
https://ncbi.nlm.nih.gov/pubmed/21697394
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-10-0779
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky